SAN FRANCISCO, CA / ACCESSWIRE / December 20, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the name of its majority owned subsidiary changed from Napo EU S.p.A. to Napo Therapeutics S ...
Company says Salix failed to progress drug to NDA-filing stage despite achieving success in Phase III over a year ago. Napo Pharmaceuticals ended its agreement with Salix Pharmaceuticals covering ...
In May of 2015, Jaguar Animal Health ($JAGX) was spun out of Silicon Valley’s Napo Pharmaceuticals with hopes of capitalizing on Wall Street’s enthusiasm for ...
Three years ago, Salix Pharmaceuticals (NASDAQ:SLXP) licensed a promising compound with the goal of developing a new treatment for chronic diarrhea in HIV patients. Morrisville, North Carolina-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback